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Abstract 
Concentrations of polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls 
(PCBs) and some organochlorine pesticides (OCPs) were determined -for the first time- 
in serum of Egyptian colorectal cancer patients (n=35) and compared to a healthy 
control group (n=32). p,p`-DDE (the major metabolite of DDT) was the most frequently 
detected contaminant with the highest concentration (median = 131 ng/g lw) in all 
studied serum samples. BDE-209 was the least frequently detected contaminant with a 
median concentration <0.3 ng/g lw. The contamination profile in patients and controls 
was almost identical with p,p`-DDE showing the highest median contribution (77%) and 
oxychlordane the lowest (1%). The low p,p`-DDT/p,p`-DDE ratio (3.7%) in serum 
implies bioaccumulation and past exposure to DDT (c.f. recent and ongoing intake) . 
Statistical analysis revealed no significant differences (P>0.05) between the levels of 
target contaminants in serum of patients and the control group. Gender, age and body 
mass index (BMI) were investigated as potential factors influencing serum contaminant 
levels. ΣDDT, hexachlorobenzene and pentachlorophenol concentrations showed 
significant positive associations with age and/or BMI of the participants. Comparison 
with other countries revealed concentrations of PBDEs and PCBs in Egyptian serum 
among the lowest reported worldwide. 
 
Keywords: Organohalogen contaminants, OCPs, PBDEs, PCBs, Egyptian blood, 
Colorectal cancer 
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Introduction 
Organohalogen contaminants (OHCs) are a diverse group of chemicals including 
organochlorine pesticides (OCPs), polychlorinated biphenyls (PCBs) and 
polybrominated diphenyl ethers (PBDEs). Despite their various applications, these 
compounds are highly lipophilic, persistent in the environment and capable of 
bioaccumulation and biomagnification along the food chain.1, 2 Moreover, numerous 
toxicological studies have associated different OHCs with adverse health effects 
including endocrine disruption, reproductive, developmental and neurological toxicity, 
type 2 diabetes and different types of cancer.3-6  Combined with their ubiquitous 
distribution in almost all biotic and abiotic environmental compartments, these features 
have led to global concern over the production and use of OHCs. As a result, most OCPs, 
PCBS and PBDEs are currently listed as persistent organic pollutants (POPs) under the 
UNEP Stockholm Convention.1  
While the regulatory actions have led to levelling off and even slight decline of the 
environmental concentrations of various OHCs in different regions, human exposure to 
these contaminants still occurs via direct and indirect pathways.7 Several authors have 
documented the association between certain types of food (e.g. fish) and elevated serum 
levels of OCPs and PCBs,8, 9 while others established significant positive correlations 
between PBDEs in indoor dust and their serum levels.10 Recently, dermal uptake has 
been highlighted as a potential pathway of human exposure to PCBs and PBDEs. 11    
Due to their relevance for public health and associations with various diseases, several 
countries have collected extensive data on the occurrence and levels of OHCs in their 
population.12-15 However, very little is known about the concentrations of OHCs in the 
blood of the Egyptian population. Furthermore, epidemiological studies have raised 
concerns over the increased incidence of colorectal cancer among the Egyptian 
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population, especially that patients under age 40 constitute 35.6% of all colorectal 
cancer cases in Egypt.16, 17 Few authors have investigated genetic, dietary and life-style 
factors as potential determinants for the increased incidence of colorectal cancer in 
Egypt. Abdel-Rahman et al. reported an association between polymorphisms in the gene 
for the DNA repair enzyme XRCC1 with increased risk of colorectal cancer among 
Egyptians. Interestingly, an association between the studied polymorphisms and early 
age of disease onset was observed.18 An epidemiological study of cancer of all organ 
sites in Gharbiah Province of Egypt from 1999 to 2002 revealed higher urban than rural 
incidences among both men and women for colorectal cancer.19 This was linked to 
dietary preferences of the urban population with higher contribution of meat and fat as 
opposed to vegetables. Dietary risk factors were further highlighted by the results of 
another study from Minia governorate, where the most significant dietary and lifestyle 
colorectal cancer risk factors were higher consumption of red meat, preserved food, 
artificial sweeteners and fast foods.20 However,  the relationship between exposure to 
chemical environmental contaminants and colorectal cancer in Egypt is yet to be fully 
explored. This may be partly attributed to the lack of information on the levels of 
different OHCs in the Egyptian population. Therefore, the aims of the current study are: 
(a) to provide first insights into the occurrence and levels of PBDEs, PCBs in addition to 
some OCPs in serum of Egyptian colorectal cancer patients, (b) to compare the levels of 
target OHCs in serum of patients to an age- and sex- matched control group, (c) to 
investigate possible correlations between the levels of OHCs in patients and their age, 
sex or body mass index (BMI) and finally (d) to compare the levels of target OHCs in the 
Egyptian serum with those reported from other countries.     
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Materials and Methods    
Target Compounds 
The OHCs investigated in this study include: 
(a) Polychlorinated biphenyls (PCBs) no. 118, 138, 153, 170, 180. 
(b) Polybrominated diphenyl ethers (PBDEs) no. 47, 99, 100, 153, 154, 183, 209 
(c) Organochlorine pesticides, namely: pentachlorophenol (PCP), hexachlorobenzene 
(HCB), oxyhchlordane (OxC), 4,4`-dichlorodiphenyldichloroethylene (p,p′-DDE) and 
4,4`-dichlorodiphenyltrichloroethane (p,p′-DDT).  
Reagents and chemicals 
Solvents and chemicals used for analysis were of HPLC grade (Sigma-Aldrich, St. 
Louis, MO 63103 USA). Oasis® HLB SPE cartridges (6 mL/500 mg, 30 µm) were 
obtained from Waters (Milford, MA 01757 USA), while empty polypropylene cartridges 
(3 mL) and corresponding frits were purchased from Supelco (Bellefonte, PA, USA). 
Individual standards of OCPs and PCBs were obtained from Dr.Ehrenstorfer 
Laboratories (Augsburg, Germany), while PBDEs standards were purchased from 
Wellington Laboratories (Guelph, ON, Canada).  
Sample collection 
Blood samples (5 mL, n=35) were collected from colorectal cancer patients admitted to 
the South Egypt Cancer Institute (SECI) between October and December 2012, while 
control samples (n=32) were obtained from the Upper Egypt Blood Bank from healthy 
donners at the same period. Informed consent was obtained from each participant 
following approval of the research protocol by the SECI ethics committee. Selection 
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criteria included Egyptian nationality, living in the Upper Egypt region for the last 8 
years and lack of occupational exposure to any of the studied chemicals. Exclusion 
criteria were family history of colorectal cancer, patients with a primary cancer other 
than colorectal cancer and severely ill cases. The controls were healthy, unrelated to the 
patients, from the same geographical area and with no family history of colorectal 
cancer. Demographic information on the participants’ age, sex and BMI are provided in 
table SI-1.  
The serum was separated by centrifugation, transferred to clean tubes and kept frozen 
at −20°C until analysis. Cholesterol and triglycerides were determined at the collection 
clinic using routine laboratory analysis then the value for total lipids (TL) was estimated 
according to the method of Phillips et al. 21 
Sample extraction and clean-up 
Sample extraction and clean-up were performed according to a previously reported 
method.22 Briefly, thawed and homogenized serum samples (~3 mL) were spiked with 
internal standards mixture (BDE-77, BDE-128, 13C-BDE-209, PCB 143, Ɛ-HCH), then 
mixed with 2 mL of milliQ-H2O and 50 µL of formic acid prior to ultrasonication for 20 
min. The equilibriated samples were loaded onto pre-conditioned Oasis HLB cartridges, 
rinsed with 4 mL of milliQ-H2O and dried under vacuum. Target analytes were eluted 
with 10 mL of DCM:MeOH (4:1, v/v) and 2.5 mL of hexane. The eluate was dried under a 
gentle stream of N2 and resolubilized in 500 µL of hexane:DCM (9:1, v/v). 
The crude extract was cleaned-up over 800 mg of pre-washed silica topped with 100 mg 
of 10% acid silica packed in 3 mL polypropylene SPE cartridges. PCBs, PBDEs and DDTs 
were eluted first by 8 mL of hexane, followed by PCP in 10 mL of DCM. The 1st fraction 
was evaporated and redissolved in 80 μL of isooctane containing 100 pg/µL of PCB129 
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and 13C-BDE-100 used as recovery determination (syringe) standards (RDS) for quality 
assurance/quality control (QA/QC) purposes. The 2nd fraction was derivatized by 
methylation and finally redissolved in 80 μL of iso-octane containing 100 pg/µL of 
PCB129 used as RDS. Further details are provided in the SI section. 
Gas chromatography/mass spectrometry (GC/MS) analysis 
Instrumental analysis of target analytes was performed using a FOCUS GC coupled to a 
DSQII mass spectrometer (Thermo Fisher Scientiﬁc, Austin, TX, USA).  Separation of 
target analytes was achieved on an Agilent DB-5 column (15m x 0.25mm; 0.1 µm). The 
mass spectrometer was run in selected ion monitoring (SIM) with ion source, 
quadrupole and mass transfer line temperatures set at 230, 150 and 300 °C, 
respectively. Further details of the GC/MS methods22 are provided in the SI section. 
QA/QC 
A multi-stage QA/QC protocol was adopted to investigate the accuracy and precision of 
the applied analytical method at different stages. Five-point calibration curves were 
created for all the analytes with a good linearity (R2 ≥ 0.986) across the studied 
concentration range. None of the target compounds was above the detection limit in 
procedural blanks (n=8) analysed alongside the serum samples. Method accuracy and 
precision were evaluated via replicate analysis (n=5) of NIST SRM1958 (organic 
contaminant in human serum). Our results compared favourably with the certified 
concentrations of all target compounds (Figure SI-1) indicating good accuracy and 
precision of the applied method. Good recoveries (72-114%) were obtained for all the 
surrogate standards.  
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Statistical analysis 
Statistical analysis of the data was conducted using Excel (Microsoft Office 2010) and 
SPSS version 22.0. Statistical distribution within each dataset was evaluated using 
Kolmogorov-Smirnov goodness of fit tests. The results - combined with visual inspection 
of frequency diagrams - revealed concentrations in all data sets to deviate significantly 
from the normal distribution. Hence, further statistical analysis was performed using 
non-parametric tests (e.g. Wilcoxon signed rank test and Spearman rank order 
correlation). In all instances, where concentrations were ≤ LOQ, (limit of quantification) 
concentrations were assumed to equal half the LOQ (Table SI-2) and P values <0.05 
were considered significant. 
Results and discussion 
Occurrence and levels of OHCs in Egyptian serum 
All target PCBs, PBDEs and OCPs were detected in the analysed serum samples. A 
statistical summary of target OHCs concentrations in the analysed samples is provided 
in Table 1 (the full dataset is given in Table SI-5). p,p`-DDE was the only target 
compound to be detected in all the analysed serum samples, with the highest median 
concentration (131 ng/g lw, n=67). BDE-209 was the least frequently detected 
contaminant (detection frequency = 36%) with a median concentration below the 
method LOQ. Interestingly, the OHC contamination profile in patients and control was 
almost identical. ΣDDT (calculated as p,p`-DDE + p,p`-DDT) showed the highest median 
contribution to the OHC profile in serum of patients and control (77%), while 
oxychlordane showed the lowest contribution (1%) (Figure 1).  This is not dissimilar to 
previous reports of OHC profiles in serum of non-occupationally exposed adults from 
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Romania, Belgium, Pakistan, Saudi Arabia, USA and Canada.12, 22-24 Predominance of 
p,p`-DDE as the major OHC in serum has been attributed to a combination of factors 
including continuous exposure via diet or breast milk, high bioaccumulation potential 
and biomagnification along the food chain, in addition to long elimination half-life 
(median t0.5 of p,p`-DDE in human serum was more than 8 years).25 Moreover, while 
DDT is listed under the Stockholm Convention on POPs, several countries in Africa, Asia 
and Latin America still use DDT for vector control. This can halter the international 
efforts to reduce the global contamination levels with this chlorinated pesticide, due to 
its environmental persistence and potential for long-range atmospheric transport. In 
Egypt, DDT was used as a pesticide for cotton fields (1952-1971) with reported 
stockpiles of 600 tons. 26 It has been officially prohibited from agricultural use since 
1980, and in 1996 a Ministerial Decree prohibited the import and use of multiple 
pesticides including DDT in Egypt.26 While the higher levels of p,p`-DDE (the main 
metabolite of DDT)  compared to  p,p`-DDT in Egyptian serum (Table 1) is expected 
given its longer half-life and bioaccumulation potential, the ratio between p,p`-
DDT/p,p`-DDE can be used to differentiate between current and historical exposures to 
this pesticide.27 The low p,p`-DDT/p,p`-DDE ratio (3.7%) in this study implies high 
environmental persistence and bioaccumulation (c.f. recent and ongoing intake) as the 
major sources of DDT exposure.27   
A literature survey revealed one study reporting levels of p,p`-DDE, p,p`-DDT and HCB 
in Egyptian colorectal cancer patients (n=31) and control (n=17) serum samples 
collected in 1996.28 Notwithstanding the caveats related to the analytical methodology 
applied at this time, the median concentrations of p,p`-DDE, p,p`-DDT and HCB in the 
current study are approximately half of those reported in 1996.28 Similarly, Tawfic et al. 
reported mean ΣPCBs concentrations of 54 ± 17, 59 ± 23 and 61 ± 21 ng/g whole weight 
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in serum samples of Egyptian females diagnosed with invasive adenocarcinoma of the 
breast (n=43), suffering benign breast disease (n=21) and normal healthy females 
(n=11), respectively.29 These levels reported in the year 2000 are substantially higher 
than mean ΣPCBs in serum of colorectal cancer patients and control group in the 
present study (Table 1).  This is generally in agreement with the globally observed 
decrease in the levels of these legacy POPs in the environment and humans as a result of 
various legislations that ban their production and use.30  
To the authors’ knowledge, this is the first study to provide levels of PCP, OxC, and 
PBDEs in Egyptian serum or any other human matrices, which precludes any discussion 
of the temporal trends of these contaminants in the Egyptian population.     
Comparison of OHC levels in serum of patients and control group  
Due to the non-parametric distribution of the generated datasets, Wilcoxon signed rank 
test was used to compare the differences in median and distribution between the 
concentrations of target OHCs in colorectal cancer patients and the control group. No 
statistically significant differences (P>0.05) were observed between the levels of 
individual target OHCs, ΣPCBs, ΣOCPs, ΣPBDEs and ΣOHCs in serum of colorectal cancer 
patients and the control group (Table SI-4). The median percent contribution of the 
studied OHCs to the overall contamination profile in serum of patients and control 
group was almost identical (Figure 1). Interestingly, the mono-ortho-PCB 118 was the 
only investigated contaminant showing border line significant difference (P=0.053) 
between its concentrations in serum of patients (median = 2.9 ng/g lw) and control 
group (median = 0.5 ng/g lw). This is in line with the findings of Howsam et al. who 
reported an elevated risk of colorectal cancer in Catalan population (n= 137, controls = 
76) associated with higher serum concentrations of mono-ortho PCB congeners 28 and 
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118, while HCB and p,p'-DDE produced no significant increases in colorectal cancer 
risk.31  Similarly, a previous study from Egypt reported no significant differences in 
levels of p,p'-DDE, p,p’-DDT and HCB, in serum of colorectal cancer patients (n= 31) 
compared to a healthy control group (n = 17).28 However, other studies from Tunisia (n 
= 69, controls = 56 females) and Singapore (n = 60, controls = 60 males) have indicated 
positive associations between concentrations of p,p'-DDE and various PCBs in serum 
and the risk of breast and prostate cancers, respectively.32, 33 Therefore, bearing in mind 
the relatively small sample number; the lack of significant differences between serum 
levels of OHCs in colorectal cancer patients and the control group in the current study 
should be interpreted with caution. More research is required on a larger sample size to 
confirm these findings.       
Factors affecting the levels of OHCs in Egyptian serum 
Gender, age and BMI were investigated as potential factors influencing the levels of 
target OHCs in the studied serum samples. The use of other socio-economic factors (e.g. 
profession, location, diet, income and education) was not allowed by the Ethics 
Committee to maintain the anonymity of the study participants.  
No statistically significant differences (Wilcoxon signed rank test, P>0.05) were 
observed between the concentrations of OHCs in the serum of males and females among 
the colorectal cancer patients and the control group. Therefore, we pooled the results 
from both males and females to study possible associations between contaminant levels 
in serum, age and BMI of the study participants in the patients and control group (Table 
2). Results revealed a significant positive correlation between the levels of ΣDDT and 
the age of the blood donners (Table 2). Previous studies from France (n = 386, aged 18-
74 years, randomly selected among the participants in the French Nutrition and Health 
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Survey),34 Spain (n= 1259 pregnant women, aged >16 to 40 years),35 USA (n=192 
healthy females, aged 45 to 85 years)36 and UK (n=153 healthy volunteers, aged 22-80 
years)15 have also reported significant increase of serum DDT concentrations with age. 
This can be explained by the long half-life and high bioaccumulation potential of DDT, 
combined with decreased metabolism and elimination of OCPs with increasing age27. 
Despite its lipophilic nature, published results differ with regard to the association 
between DDT serum levels and BMI.12 While ΣDDT was significantly correlated with 
BMI in the present study, no significant association was observed in French adults 
(despite half the population with BMI > 25 including 15% with BMI >30).34 This may be 
attributable to differences in exposure (e.g. diet) and socioeconomic (e.g. profession) 
factors influencing the serum levels of OHCs in different populations.34 It’s worth 
mentioning that the concentrations of p,p`-DDE in the present study contributed 96 ± 
23%  and 83 ± 34% to ΣDDT and ΣOCPs, respectively. Therefore, it’s reasonable to 
conclude that the significant positive associations of serum ΣDDT and ΣOCPs with 
participants age and BMI (Table 2) are driven mainly by the concentrations of p,p`-DDE.  
Interestingly, PCP levels, the second largest contributor to serum ΣOCPs, showed a 
significant positive correlation with ΣDDT concentrations in both the patients and 
control groups (Table 2). There is no clear explanation for this strong correlation. In 
addition to direct exposure via diet, it has been suggested that PCP in serum can result 
from HCB metabolism.23 Since no significant correlation was observed between the 
levels of ΣDDT and HCB or PCP and HCB in serum (Table 2), it is likely that the 
correlation between ΣDDT and PCP concentrations originate from common exposure 
sources to these two contaminants (e.g. diet).  
PCP levels were significantly correlated to BMI in the serum of the control group. A 
possible explanation for this association is that BMI could alter PCP toxicokinetics and 
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accumulation of the compound in body fat resulting in increased internal concentration 
in obese individuals.37 HCB levels showed a significant correlation with patients’ age 
(Table 2), which may be attributable to bioaccumulation resulting in increased serum 
concentrations with age.12, 34 
Comparison with other countries   
The concentrations of target OHCs in the analysed Egyptian serum samples (n=67, 
patients + control group) were compared to those reported previously from other 
countries (Figure 2 and Table SI-6). While we are aware that studies from different 
countries have targeted various populations (e.g. pregnant women, males, diabetic 
patients and general population) of different age groups with different lifestyles and 
habits, we believe that such comparison is beneficial to provide a general perspective of 
the measured concentrations of target OHCs in human blood from Egypt compared to 
other parts of the world. This is of particular interest given the global distribution of the 
studied contaminants and the synchronised international efforts required to minimize 
exposure and reduce human body burdens of these OHCs.   
Median HCB level (5.9 ng/g lw) in Egyptian serum was at the lower end of this 
contaminant concentrations reported globally. This is consistent with low serum HCB 
concentrations in other developing countries like Saudi Arabia (n=60, 40 diabetic 
patients and 20 healthy controls),24 Pakistan (n=85, 34 mothers, 34 children (3-10 years) 
and 17 general population)22 and Bangladesh (n=24 males) .38 Higher serum HCB 
concentrations were reported from China (n=26, median = 39 ng/g lw)39, Spain 
(n=2433, median = 34 ng/g lw)40 and USA (n = 341 males, 15 ng/g lw).41 This may 
reflect less historical use of HCB in the developing countries. In Egypt, HCB was detected 
at concentrations of 4 - 93 ng/L in water samples collected at different locations along 
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the river Nile in 1995. It was also detected at low levels in Egyptian fish (2.5-20 ng/g 
wet weight) and vegetables (3-9 ng/g wet weight)42, indicating dietary intake as the 
predominant source of human exposure to HCB.     
PCBs in Egyptian serum showed a similar profile to that reported from other countries 
with PCB 138 as the predominant congener (median = 4.93 ng/g lw) followed by PCB 
153 (median = 2.83 ng/g lw). However, median serum ΣPCBs in this study (10.36 ng/g 
lw) was lower than those reported elsewhere (Figure 2). This is generally in line with 
low PCB residues found in the Egyptian terrestrial and aquatic environment, which was 
attributed to the low industrial profile of the country until the 1970s.43 
Unlike PCBs, the median serum concentration of p,p`-DDE in the current study (131 
ng/g lw) was higher than those reported in blood samples from the general population 
of UK (n=153, 100 ng/g lw)15, Belgium (n=204, 64 ng/g lw) 12 and Canada (n= 5000, 63 
ng/g lw). 12 DDT was never used for Malaria control in Egypt. However, it was widely 
applied to treat cotton fields from 1952 to 1971. In the 1970s, DDT usage decreased 
gradually due to the resistance developed by the cotton leafworm, Spodoptera littoralis , 
until it was officially prohibited from all agricultural applications in 1980.26 DDTs 
(dominated by p,p`-DDE) were detected in Egyptian fresh water (3-1048 ng/L), 
vegetables (1.78-2.82 ng/g), meat (67 ng/g fat) and fish (8-91 ng/g wet weight) 
products, indicating widespread contamination of the Egyptian environment with 
DDT.42  
Fewer studies have reported on the levels of PCP and oxychlordane in serum from 
different countries. The median serum level of PCP in the current study (229 pg/mL) 
was lower than those reported in serum samples of pregnant women from the 
Netherlands (n=69, median = 970 pg/mL) and Sweden (n=15, 2830 pg/mL)44 as well as 
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Norwegian women (n=281, 771 pg/mL)9, but higher than the concentrations reported 
from Japan (n = 20 males, 140 pg/mL)45 and Pakistan (130 pg/mL).22  
OxC is the oxidised, relatively more polar metabolite of the pesticide Chlordane, which 
is more likely to be detected in serum. Median level of OxC in Egyptian serum was below 
LOQ, (<1.5 ng/g lw) with a detection frequency of 39%. This is consistent with the very 
low detection frequency of Chlordane in the Egyptian environment.42    
To the authors’ knowledge, this is the first study to report PBDE levels in Egyptian 
serum. BDE-47 was the most frequently detected congener (87%) with the highest 
median level (0.97 ng/g lw), followed by BDE-99 (77%, 0.61 ng/g lw). This is consistent 
with previous studies from other countries, indicating exposure to the penta-BDE 
commercial formulation.46 Median penta-BDE level (1.9 ng/g lw, sum of congeners 47, 
99, 100, 153 and 154) in Egyptian serum was at the lower end of those reported from 
other countries (Figure 2). A recent study reported low concentrations of PBDEs in dust 
samples collected from Egyptian homes (n=17, median penta-BDE = 5.2 ng/g), 
workplaces (n=9, 11.6 ng/g) and cars (n=5, 35.6 ng/g).47 Indoor dust was highlighted as 
the major pathway of human exposure to PBDEs via ingestion and dermal contact.48 
Therefore, the low levels of PBDEs in Egyptian serum samples can be explained by the 
low concentrations of these flame retardants in Egyptian indoor dust.  
BDE-209 (the major congener of the deca-BDE mixture) and BDE-183 (the indicator 
congener for octa-BDE mixture) were detected in Egyptian serum at lower frequency 
and concentrations than the penta-BDE congeners (Table 1). This may be attributed to 
the high lipophilicity and molecular weight of these congeners, which is likely to reduce 
their bioavailability to humans following exposure via indoor dust or diet. Moreover, 
the short serum half-life of BDE-209 (7-14 days) indicates that the detected levels in 
serum likely reflect recent exposure of the participants, rather than prolonged chronic 
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exposure.49 Overall, the concentrations of PBDEs detected in Egyptian serum in this 
study are among the lowest reported worldwide.  
Limitations and strengths 
The current study doesn’t aim and can’t qualify to be an epidemiological case-control 
study. This is mainly due to the ethical restrictions which limited the public disclosure 
of risk factors to age, gender, and BMI; excluding other known important factors to 
ensure participant anonymity. In addition, the relatively small sample size combined 
with the 3 risk factors studied can only detect odds ratios of 4 ~5 (or higher) with 
sufficient statistical power. Uncertainties in the study also include the degree of 
representability of the studied samples to the general population given the overall small 
number of participants and the relatively high average BMI observed for both the 
patients and control group (Table 1).  
However, this work provides the first human biomonitoring data of various OHCs in the 
Egyptian population, which significantly augments the current knowledge about the 
global distribution of these contaminants. Furthermore, due to the general lack of 
statistically significant differences between the patients and control group, the current 
paper focuses on characterising the levels and profiles of a broad suite of OHCs in 
Egyptian blood in comparison to previous reports from other countries and regions. 
This provides novel insights into the internal human exposure to contaminants like 
PBDEs and other OCPs in Egypt, which may trigger further regulatory and/or 
socioeconomic actions to reduce human exposure to these hazardous chemicals in the 
developing countries.               
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Tables 
Table 1: Statistical summary of the concentrations (ng/g lipid weight) of target OHCs in Egyptian serum samples.  
 Patients (n=35,  19 males and 16 females) Control (n=32, 17 males and 15 females) 
 DF* (%) Median Average SD Min Max DF (%) Median Average SD Min Max 
Age  47 48 9 34 62  43 44 9 31 61 
BMI  29 31 6 23 43  32 33 7 19 48 
PCB-118 70 1.34 1.91 1.92 <LOQ 6.88 69 0.50 1.52 1.82 <LOQ 6.10 
PCB-138 91 4.93 5.41 3.30 <LOQ 12.45 94 5.00 4.92 3.03 <LOQ 12.86 
PCB-153 80 2.66 3.01 2.50 <LOQ 10.17 66 3.03 3.11 2.59 <LOQ 8.03 
PCB-170 60 0.48 0.78 0.99 <LOQ 4.66 63 0.52 0.65 0.80 <LOQ 4.36 
PCB-180 57 0.27 0.57 0.76 <LOQ 3.14 56 0.33 0.58 0.69 <LOQ 3.35 
ΣPCBs  10.17 11.67 6.22 <LOQ 28.63  10.76 10.78 5.45 <LOQ 21.94 
pp-DDE 100 126.26 230.95 275.21 8.44 1061.65 100 139.75 184.98 205.39 12.18 930.40 
pp-DDT 34 <LOQ 8.49 10.35 <LOQ 47.65 53 4.58 8.31 7.17 3.14 33.56 
ΣDDT  133.97 239.44 281.40 12.44 1109.29  145.24 193.29 212.21 16.18 960.11 
HCB 86 5.87 6.37 3.85 <LOQ 14.04 81 6.41 6.60 4.81 <LOQ 18.34 
OxC 46 1.50 2.10 0.93 <LOQ 5.28 31 1.50 1.87 0.89 <LOQ 5.12 
PCP 89 17.99 33.26 45.87 <LOQ 192.51 94 15.97 28.73 35.48 <LOQ 142.54 
ΣOCPs  155.85 281.17 314.65 25.01 1279.01  168.40 230.48 244.42 28.88 1114.83 
BDE-47 86 0.88 1.65 1.95 <LOQ 7.33 88 1.13 1.89 2.19 <LOQ 8.31 
BDE-100 57 <LOQ 0.56 0.85 <LOQ 3.29 66 0.19 0.52 0.68 <LOQ 2.43 
BDE-99 80 0.50 1.30 1.63 <LOQ 6.11 75 0.71 1.40 1.66 <LOQ 6.81 
BDE-154 34 <LOQ 0.38 0.72 <LOQ 3.02 50 0.04 0.25 0.44 <LOQ 2.23 
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BDE-153 54 0.11 0.53 0.89 <LOQ 3.78 69 0.20 0.44 0.61 <LOQ 2.80 
BDE-183 57 0.29 0.52 0.64 <LOQ 2.22 56 0.31 0.57 0.67 <LOQ 2.08 
BDE-209 34 <LOQ 4.03 6.39 <LOQ 21.39 41 <LOQ 4.62 7.05 <LOQ 25.40 
ΣPBDEs  5.95 8.96 7.98 <LOQ 25.99  7.84 9.69 8.78 <LOQ 41.17 
* Detection frequency. 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
27 
Table 2: Spearman rank order correlations among serum concentrations of OHCs, age 
and BMI of the study participants. 
Patients (n=35) Age BMI ΣPCBs** ΣDDT# HCB OxC PCP ΣOCPs$ 
BMI 
R 0.223        
P 0.197        
ΣPCBs 
R 0.025 -0.029       
P 0.889 0.868       
ΣDDT 
R 0.349* 0.343* 0.089      
P 0.04 0.044 0.613      
HCB 
R 0.386* -0.015 0.157 0.089     
P 0.022 0.931 0.367 0.611     
OxC 
R -0.04 -0.246 -0.071 0.129 -0.027    
P 0.818 0.154 0.687 0.461 0.877    
PCP 
R 0.038 0.265 0.007 0.463* -0.198 0.278   
P 0.83 0.124 0.966 0.005 0.254 0.107   
ΣOCPs 
R 0.323 0.348* 0.085 0.989* 0.098 0.16 0.549*  
P 0.058 0.04 0.626 0.001 0.576 0.357 0.001  
ΣPBDEs+ 
R 0.054 0.062 -0.206 -0.084 0.191 -0.143 -0.149 -0.141 
P 0.759 0.723 0.236 0.63 0.272 0.418 0.421 0.419 
Control (n=32) Age BMI ΣPCBs ΣDDT HCB OxC PCP ΣOCPs 
BMI 
R 0.321        
P 0.073        
ΣPCBs 
R 0.058 0.175       
P 0.751 0.339       
ΣDDT 
R 0.399* 0.437* 0.023      
P 0.024 0.012 0.901      
HCB 
R 0.233 0.163 0.146 -0.031     
P 0.199 0.373 0.425 0.865     
OxC 
R 0.198 -0.068 0.275 0.214 -0.211    
P 0.276 0.712 0.127 0.239 0.247    
PCP 
R 0.177 0.370* 0.021 0.694* 0.038 0.174   
P 0.331 0.037 0.909 0.001 0.836 0.342   
ΣOCPs 
R 0.407* 0.480* 0.042 0.991* 0.018 0.173 0.736*  
P 0.021 0.005 0.820 0.001 0.923 0.344 0.001  
ΣPBDEs 
R -0.341 -0.124 -0.254 -0.115 -0.291 -0.058 0.124 -0.123 
P 0.056 0.499 0.160 0.530 0.106 0.753 0.500 0.503 
* Statistically significant at the 0.05 level. 
** Sum of PCB congeners 118, 138, 153, 170 and 180. 
# Sum of p,p`-DDE and p,p`-DDT. 
$ Sum of p,p`-DDE, p,p`-DDT, HCB, OxC and PCP. 
+ Sum of PBDE congeners 47, 99, 100, 153, 154, 183 and 209. 
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Figures 
Figure 1: Median profile of the studied OHCs in serum samples of (a) colorectal cancer patients (n=35) and (b) control group (n=32). 
 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
29 
Figure 2: Median concentrations (ng/g lw) of HCB, ΣPCBs, Prnta-BDEs and p,p`-DDE in human serum samples from different countries. 
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Research	Highlights	
• PBDEs, PCBs and OCPs were determined in 67 human blood samples from Egypt 
• No significant differences between colorectal cancer patients and control group 
• ΣDDT and ΣOCPs increased significantly with age and BMI 
• PBDEs and PCBs in serum of Egyptians are among the lowest worldwide 
